Literature DB >> 7541186

Astemizole in the treatment of granulocyte colony-stimulating factor-induced bone pain.

R Gudi, M Krishnamurthy, B R Pachter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7541186     DOI： 10.7326/0003-4819-123-3-199508010-00019

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

1.  Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim.

Authors:  J Moukharskaya; D M Abrams; T Ashikaga; F Khan; J Schwartz; K Wilson; C Verschraegen; T Openshaw; J Valentine; J Eneman; P Unger; S Ades
Journal:  Support Care Cancer       Date:  2016-02-19       Impact factor: 3.603

2.  Predictive factors in patients eligible for pegfilgrastim prophylaxis focusing on RDI using ordered logistic regression analysis.

Authors:  Yuko Kanbayashi; Takeshi Ishikawa; Motohiro Kanazawa; Yuki Nakajima; Rumi Kawano; Yusuke Tabuchi; Tomoko Yoshioka; Norihiko Ihara; Toyoshi Hosokawa; Koichi Takayama; Keisuke Shikata; Tetsuya Taguchi
Journal:  Med Oncol       Date:  2018-03-16       Impact factor: 3.064

3.  Canadian supportive care recommendations for the management of neutropenia in patients with cancer.

Authors:  C T Kouroukis; S Chia; S Verma; D Robson; C Desbiens; C Cripps; J Mikhael
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.